VERZÖGERT FREISETZENDE FORMULIERUNGEN VON OXYMORPHON

Patent europeic · EP1404331 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1404331
Numer da la dumonda
EP02744835
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
03-07-2002
Publitgà
07-04-2004
Concedì
31-10-2007
Stritgà
31-10-2007
Motiv
Nagin effect per la Svizra ed il Liechtenstein
Classas IPC
A61K 31/485 (2006.01)
A61K 9/20 (2006.01)
A61P 25/04 (2006.01)
Prioritad
US 303357 P 06.07.2001
US 329352 P 15.10.2001
US 329426 P 15.10.2001
Dumonda PCT
PCT/US2002/021403 03.07.2002
Publicaziun PCT
WO2003/004033 16.01.2003
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 15-05-2008

    Midada

    Published in +pat+ No 9 in 2008

  2. 30-11-2007

    Concedì

    Published in +pat+ No 22 in 2007

Partidas

Possessur

Penwest Pharmaceuticals Co.

2981 Route 22, Patterson, NY 12563-9970, US

Inventur

BAICHWAL, Anand, R.

Wappingers Falls, NY 12590, US

KAO, Huai-Hung

Syosset, NY 11791, US

MCCALL, Troy, W.

Germantown, TN 38138, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.